ES2118292T3 - Metodo para la preparacion de 3-hidroxi-5-(2-dimetilamino)-etil)-2,3-dihidro-4-(metoxifenil)-1,5-benzotiazepin-4(5h)-ona y uso del producto para elaborar compuestos farmaceuticamente activos. - Google Patents

Metodo para la preparacion de 3-hidroxi-5-(2-dimetilamino)-etil)-2,3-dihidro-4-(metoxifenil)-1,5-benzotiazepin-4(5h)-ona y uso del producto para elaborar compuestos farmaceuticamente activos.

Info

Publication number
ES2118292T3
ES2118292T3 ES94114643T ES94114643T ES2118292T3 ES 2118292 T3 ES2118292 T3 ES 2118292T3 ES 94114643 T ES94114643 T ES 94114643T ES 94114643 T ES94114643 T ES 94114643T ES 2118292 T3 ES2118292 T3 ES 2118292T3
Authority
ES
Spain
Prior art keywords
active compounds
pharmaceutically active
product
hydroxy
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94114643T
Other languages
English (en)
Inventor
Martti Hytonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fermion Oy
Original Assignee
Orion Yhtyma Fermion Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Fermion Oy filed Critical Orion Yhtyma Fermion Oy
Application granted granted Critical
Publication of ES2118292T3 publication Critical patent/ES2118292T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN METODO PARA LA PREPARACION DE 3-HIDROXI-5 (DIMETILAMINO)ETIL1)}-2,3-DIHIDRO-4-{(METOXIFENIL-1,5BENZOTACEPI-4{(5H-ONA Y EL USO DEL PRODUCTO PREPARADO POR ESTE METODO PARA ELABORAR COMPOSICIONES Y COMPUESTOS FARMACEUTICAMENTE ACTIVOS EMPIEZA CON N-ALKILACION DE 3-HIDROXI2,3DIHIDRO-4-{(METOXIFENIL-1,5-BENZOTIACEPIN-4{(5-ONA CON UN HALURO {(DIMETILAMINOETILO DONDE LA REACCION DE N-ALKILACION SE REALIZA EN UNA MEZCLA DE REACCION QUE COMPRENDE 2-BUTANONA Y AGUA. EL PRODUCTO DE ESTA REACCION Y SUS SALES TIENEN UTILIDAD COMO COMPUESTOS FARMACEUTICAMENTE ACTIVOS Y COMO INTERMEDIOS PARA ELABORAR COMUESTOS FARMACEUTICAMENTE ACTIVOS. EL METODO PRESENTADO Y SU USO ES MAS SIMPLE, MAS EFICIENTE Y SEGURO QUE LOS ANTERIORES METODOS CONOCIDOS Y PRODUCE UN PRODUCTO DE PUREZA SUPERIOR.
ES94114643T 1994-09-16 1994-09-16 Metodo para la preparacion de 3-hidroxi-5-(2-dimetilamino)-etil)-2,3-dihidro-4-(metoxifenil)-1,5-benzotiazepin-4(5h)-ona y uso del producto para elaborar compuestos farmaceuticamente activos. Expired - Lifetime ES2118292T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94114643A EP0702009B1 (en) 1994-09-16 1994-09-16 Method for the preparation of pharmaceutically active benzothiazepine derivatives

Publications (1)

Publication Number Publication Date
ES2118292T3 true ES2118292T3 (es) 1998-09-16

Family

ID=8216292

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94114643T Expired - Lifetime ES2118292T3 (es) 1994-09-16 1994-09-16 Metodo para la preparacion de 3-hidroxi-5-(2-dimetilamino)-etil)-2,3-dihidro-4-(metoxifenil)-1,5-benzotiazepin-4(5h)-ona y uso del producto para elaborar compuestos farmaceuticamente activos.

Country Status (20)

Country Link
US (1) US5663332A (es)
EP (1) EP0702009B1 (es)
JP (1) JPH08269026A (es)
AT (1) ATE167858T1 (es)
BA (1) BA95040A (es)
CA (1) CA2158223A1 (es)
CZ (1) CZ290970B6 (es)
DE (1) DE69411387T2 (es)
DK (1) DK0702009T3 (es)
EE (1) EE03565B1 (es)
ES (1) ES2118292T3 (es)
HR (1) HRP950478B1 (es)
HU (1) HU220610B1 (es)
IL (1) IL115275A (es)
LV (1) LV11324B (es)
PL (1) PL310495A1 (es)
RU (1) RU2141957C1 (es)
SK (1) SK281219B6 (es)
YU (1) YU60395A (es)
ZA (1) ZA957703B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996038429A1 (en) * 1995-06-01 1996-12-05 Acic (Canada) Inc. Method for the manufacture of benzothiazepine derivatives
TW438787B (en) * 1997-02-27 2001-06-07 Tanabe Seiyaku Co Process for preparing optically active trans-3-substituted glycidic acid ester
DE102004010830A1 (de) * 2004-02-27 2005-09-15 Bioagency Ag Neue 1,4-Benzooxazepane oder 1,4-Benzothiazepane und Derivate
CN103304514B (zh) * 2013-06-28 2014-09-17 天津梅花医药有限公司 一种稳定性好的盐酸地尔硫卓化合物及药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS5899471A (ja) * 1981-12-07 1983-06-13 Tanabe Seiyaku Co Ltd ベンゾチアゼピン誘導体の新規製造法
IT1175814B (it) * 1984-03-09 1987-07-15 Luso Farmaco Inst Resine solfoniche ad attivita' terapeutica,loro preparazione e composizioni farmaceutiche che le contengono
JPS63275572A (ja) * 1987-05-01 1988-11-14 Tanabe Seiyaku Co Ltd １，５−ベンゾチアゼピン誘導体
FR2624117B1 (fr) * 1987-12-08 1991-02-22 Synthelabo Derives de hydroxy-3 (methoxy-4 phenyl)-2 (methylamino-2 ethyl)-5 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique
FR2630109B1 (fr) * 1988-04-19 1991-11-29 Synthelabo Derives de ((n-(amino-2 oxo-2 ethyl)methylamino)-2 ethyl)-5 hydroxy-3 (methoxy-4 phenyl)-2 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique
US5002942A (en) * 1988-07-25 1991-03-26 Sankyo Company, Limited 1,5-benzothiazepine derivatives, their preparation and their use in the treatment of cardiovascular disorders
FR2653122B1 (fr) * 1989-10-17 1994-04-15 Synthelabo Derives de 5-[2-[[2-amino-2-oxoethyl]methylamino]ethyl]-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5(5h)-benzothiazepine-4-one, leur preparation et leur application en therapeutique.
IT1240686B (it) * 1990-04-27 1993-12-17 Luso Farmaco Inst Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
IT1244878B (it) * 1990-12-11 1994-09-12 Lusochimica Spa Processo per la preparazione del (+)-cis-3-(acetossi)-5-!2-( dimetilammino)etil!-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin- 4-(5h)-one cloridrato

Also Published As

Publication number Publication date
RU2141957C1 (ru) 1999-11-27
SK281219B6 (sk) 2001-01-18
SK114195A3 (en) 1996-06-05
ZA957703B (en) 1996-04-24
HRP950478A2 (en) 1997-06-30
IL115275A (en) 2000-06-01
US5663332A (en) 1997-09-02
DK0702009T3 (da) 1999-02-01
JPH08269026A (ja) 1996-10-15
EE03565B1 (et) 2001-12-17
DE69411387T2 (de) 1999-02-25
HUT76924A (hu) 1998-01-28
EP0702009A1 (en) 1996-03-20
HU9502710D0 (en) 1995-11-28
YU60395A (sh) 1998-09-18
CZ237295A3 (en) 1996-04-17
HU220610B1 (hu) 2002-03-28
IL115275A0 (en) 1995-12-31
ATE167858T1 (de) 1998-07-15
DE69411387D1 (de) 1998-08-06
LV11324A (lv) 1996-06-20
EE9500050A (et) 1996-04-15
CA2158223A1 (en) 1996-03-17
HRP950478B1 (en) 1999-10-31
LV11324B (en) 1996-10-20
BA95040A (bs) 1998-12-28
PL310495A1 (en) 1996-03-18
EP0702009B1 (en) 1998-07-01
CZ290970B6 (cs) 2002-11-13

Similar Documents

Publication Publication Date Title
HUP9802578A3 (en) Phenylacetic acid derivatives, process and intermediates for producing them, fingicide, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients and use thereof
MX11031A (es) Proceso para la preparacion de nuevas 1-fenil-3-naftaleniloxipropanaminas producto obtenido y composicion farmaceutica que lo incluye.
CA2196995A1 (en) Spiro-azabicyclic compounds useful in therapy
ZA986904B (en) Process
NO970581L (no) Fremgangsmåte for fremstilling av 4-oksoimidazoliniumsalter
CA2354606A1 (en) Azabicycloalkane derivatives and therapeutic uses thereof
EA200100301A2 (ru) НОВЫЙ СПОСОБ ПОЛУЧЕНИЯ 11-АМИНО-3-ХЛОР-6,11-ДИГИДРО-5,5-ДИОКСО-6-МЕТИЛДИБЕНЗО[c,f][1,2]ТИАЗЕПИНА И ЕГО ПРИМЕНЕНИЕ ДЛЯ СИНТЕЗА ТИАНЕПТИНА
IE883860L (en) Novel antiarrhythmic agents ii
ES2118292T3 (es) Metodo para la preparacion de 3-hidroxi-5-(2-dimetilamino)-etil)-2,3-dihidro-4-(metoxifenil)-1,5-benzotiazepin-4(5h)-ona y uso del producto para elaborar compuestos farmaceuticamente activos.
DE3762860D1 (de) 2-thiazolylimidazo(1,2-a)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
HUT36127A (en) Process for preparing new pyrrolo-benzoxazepines
AU595167B2 (en) Indane derivatives and methods of preparation and treatment
IE860955L (en) Intermediates for the production of epipodophyllotoxin
GR861210B (en) Process for preparing novel 2,4-diphenyl -1,3- dioxanes
AP9801235A0 (en) Erythromycin derivatives.
ES2145740T3 (es) Composiciones de factor de crecimiento, preparacion y uso.
AR006553A1 (es) COMPUESTOS ESPIRO[CICLOPENT[b] INDOLPIPERIDINAS] PARTICULARMENTE UTILES PARA ALIVIAR LA DISFUNCION DE LA MEMORIA, INTERMEDIARIOS, COMPOSICIONESFARMACEUTICAS, USOS Y PROCEDIMIENTOS DE PREPARACION DE DICHOS COMPUESTOS.
AU7761587A (en) Process
DE3666588D1 (en) Spiroûbenzofuran-2(3h), 1'cycloheptane¨s, a process and intermediates for their preparation and their use as medicaments
ATE102921T1 (de) (alfa-t-butyl aminomethyl-3,4-dichlorobenzyl) thioacetamid, verfahren zu ihrer herstellung und ihre verwendung.
MD1574C2 (ro) Săruri de alchilamoniu ale acidului N,N1-malonil-bis-p-aminobenzoic, procedeu de obţinere şi utilizarea lor în calitate de remediu hipotensiv şi antiaritmic
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
HUP9900916A2 (hu) Benzotiofénszármazékok felhasználása az érszövetek kalciumvezetékeit antagonizáló hatású gyógyszerkészítmények előállítására
DE69500156D1 (de) Imidazopyridin-Derivate und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 702009

Country of ref document: ES